Increased TGFβ activity may suppress the antitumor response through inhibiting CD4+ T helper cell function, decreasing the differentiation and function of cytotoxic T cells, promoting the pro-tumor TH17 response, and recruiting immune suppressive myeloid cells into the tumor microenvironment [67]. This evidence concerns the gene CD4 and neoplasm.